导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 20.32% | 36/268 |
| 近一周 | -1.32% | 280/289 |
| 近一月 | -0.26% | 26/289 |
| 近一季 | -1.43% | 259/283 |
| 近半年 | 13.26% | 85/278 |
| 近一年 | 18.83% | 30/267 |
| 近两年 | 26.78% | 33/246 |
| 近三年 | 10.91% | 86/182 |
| 成立以来 | 65.14% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
5.05% 7/287 |
3.72% 38/293 |
13.86% 100/296 |
- - |
| 2024 | 5.16% 103/287 |
-2.15% 197/290 |
-1.48% 229/295 |
8.39% 66/292 |
0.65% 64/287 |
| 2023 | -11.10% 193/281 |
2.70% 98/236 |
-3.02% 175/256 |
-6.95% 247/271 |
-4.08% 221/281 |
| 2022 | -15.45% 89/228 |
-10.62% 84/121 |
5.81% 22/141 |
-8.84% 116/157 |
-1.92% 131/228 |
| 2021 | 9.64% 5/116 |
-1.58% 574/1745 |
3.93% 1472/2232 |
5.14% 345/2560 |
1.96% 59/116 |
| 2020 | 37.81% 5/86 |
-1.77% 518/1036 |
18.17% 767/1256 |
8.12% 825/1472 |
9.80% 1088/1690 |
| 2019 | - - |
- - |
- - |
4.61% 534/939 |
7.61% 581/1014 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 国投瑞银白银期货(LOF)A | 1.7164 | 48.92% |
| 国投瑞银白银期货(LOF)C | 1.7017 | 48.76% |
| 泰信现代服务业混合 | 2.1670 | 38.91% |
| 创金合信全球医药生物股票发起(QDII)C | 1.7789 | 37.65% |
| 泰信发展主题混合 | 1.8890 | 37.48% |
| 永赢先锋半导体智选混合发起A | 1.2881 | 28.89% |
| 永赢先锋半导体智选混合发起C | 1.2863 | 28.72% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 嘉实资源精选股票A | 4.7401 | 21.68% |
| 华商致远回报混合C | 1.6720 | 21.39% |
| 嘉实养老2050混合(FOF)A VS. () |